Around the World: 24-Hour Virtual Symposium – What to Expect
A global community of oncology pharmacy practitioners striving to advance cancer care
Around the World: 24-Hour Virtual Symposium
What to Expect
With just 42 days to go until the Around the World: 24-Hour Virtual Symposium, I am delighted to share more detail about what the 24 hours will include, with you choosing when and how often you join.
The Symposium has been designed as a 24-hour experience to ensure members around the world—regardless of time zone—can participate in live sessions and networking opportunities.
Alongside the plenary sessions (outlined below), participants will have access to regular networking opportunities through themed roundtable discussions in breakout rooms. These sessions will take place during scheduled breaks, giving participants the flexibility to rest, stretch, or join a conversation. Topics will span professional interests—such as biosimilar implementation and getting started in research—as well as lighter and wellbeing-focused themes, including hobbies like canoeing or badminton (to get to know each other), and discussions on managing workload and burnout. These roundtables aim to foster meaningful connections, encourage collaboration, and expand your global professional network.
The program will also feature 12 plenary presentations, showcasing the highest-rated abstracts across four different time zones—highlighting the best of ISOPP’s global expertise.
Registration is just 30 CAD, making this an accessible and sustainable learning opportunity for members worldwide.
| More Info | Register Here |
We encourage you to register and to share this event with colleagues on line and on socials. Your support will be instrumental in ensuring success. #ISOPP2026.
Program* highlights include:
| Symposium opening and interview with ISOPP founder Helen McKinnon |
| Thera-what?! The role of oncology pharmacy practitioners in theranostics |
| Management of Cytokine Release Syndrome (CRS) and Immune Effector Cell–Associated Neurotoxicity Syndrome (ICANS) associated with CAR-T cell therapy: a case presentation |
| Antibody–Drug Conjugates in Breast Cancer: pharmacologic precision and the pharmacist’s role in toxicity management |
| Integrative approaches in cancer care: developing evidence-based recommendations from population studies and implementation science frameworks |
| Optimizing antimicrobial use in cancer patients |
| Does malnutrition impact cancer treatment in children? |
| Challenges with implementing new pharmacy programs |
| Capacity building in low- and middle-income countries (LMICs) |
| Pharmacy practice in cancer care: yesterday, today, and tomorrow |
| Therapeutic updates in genitourinary cancers: evolving standards and emerging options |
| From evidence to access: lessons from NICE and global strategies for equitable medicines |
| Automating aseptic services |
| Developing a 3D-printing platform for oncology clinical trials |
| Pharmacy readiness for advanced therapy medicinal products (ATMPs) |
| Less is More: implementing deprescribing pathways for patients with cancer |
| Integrating CAR-T therapy into oncology pharmacy: operational, logistical, and clinical perspectives |
| Checkpoint inhibitors: clinical pearls for pharmacists |
| Advances in the management of myeloproliferative neoplasms: a pharmacist’s perspective |
| Medication donation: a sustainable approach to access and waste reduction |
| Research collaboration across borders |
*subject to change
We look forward to welcoming you online for this truly global Symposium.